{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:46:26Z","timestamp":1791639986368,"version":"4.3.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023009"],"award-info":[{"award-number":["ZYCXTD2023009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anti\u2013glomerular basement membrane (anti-GBM) disease is a rare and life-threatening form of small vessel vasculitis that primarily affects the kidneys and lungs. In rare cases, it occurs with membranous nephropathy (MN). This study aimed to investigate the clinical manifestations, pathological features, prognosis and predictors of anti-GBM disease with MN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We enrolled 24 patients with combined anti-GBM disease and MN, and 69 patients with classic anti-GBM disease (without MN). We compared the clinical and pathological differences, as well as the prognoses between the two groups and attempted to identify predictors of anti-GBM disease combined with MN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A greater proportion of patients with combined disease were male, had a history of smoking, and had nephrotic syndrome (NS). Compared with patients with classic anti-GBM disease, those with anti-GBM disease with MN presented improved renal function, higher hemoglobin and serum C3 levels, and significantly improved renal outcomes (P\u00a0&amp;lt;\u00a0.05). In 16 out of 24 double-positive patients, a lower proportion of glomerular crescents and a higher rate of immunoglobulin G4 positivity were observed compared with only 20 of the 69 patients with classic anti-GBM disease confirmed by renal biopsy (P\u00a0&amp;lt;\u00a0.05). Furthermore, smoking status, hemoglobin levels and low-density lipoprotein levels were identified as factors associated with the development of anti-GBM combined with MN, potentially serving as predictors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study provides insights into the distinct clinical and pathological characteristics of anti-GBM disease with MN. The identification of predictors may contribute to the early recognition and management of these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf014","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:36:21Z","timestamp":1741124181000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathological features and predictors of anti-GBM disease combined with membranous nephropathy"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8818-9624","authenticated-orcid":false,"given":"Yuanyuan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-1631","authenticated-orcid":false,"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2025040309385629400_bib1","doi-asserted-by":"crossref","first-page":"103212","DOI":"10.1016\/j.autrev.2022.103212","article-title":"Anti-glomerular basement membrane vasculitis","volume":"22","author":"Ponticelli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025040309385629400_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"2021 Clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO","year":"2021","journal-title":"Kidney Int"},{"key":"2025040309385629400_bib3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025040309385629400_bib4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"2025040309385629400_bib5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ekir.2019.07.021","article-title":"Membranous glomerulonephritis with crescents","volume":"4","author":"Nikolopoulou","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2025040309385629400_bib6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJM197406132902403","article-title":"Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis","volume":"290","author":"Klassen","year":"1974","journal-title":"N Engl J Med"},{"key":"2025040309385629400_bib7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ki.2013.364","article-title":"The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy","volume":"85","author":"Jia","year":"2014","journal-title":"Kidney Int"},{"key":"2025040309385629400_bib8","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1080\/0886022X.2022.2141645","article-title":"Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study","volume":"44","author":"Zhang","year":"2022","journal-title":"Ren Fail"},{"key":"2025040309385629400_bib9","doi-asserted-by":"publisher","first-page":"220208","DOI":"10.1183\/20734735.0208-2022","article-title":"Pulmonary renal syndrome: a clinical review","volume":"18","author":"Boyle","year":"2022","journal-title":"Breathe"},{"key":"2025040309385629400_bib10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.ajkd.2020.11.023","article-title":"Concurrent anti-glomerular basement membrane antibody disease and membranous nephropathy: a case series","volume":"78","author":"Ahmad","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2025040309385629400_bib11","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.ekir.2022.07.006","article-title":"Concurrent PLA2R-associated membranous nephropathy and antiglomerular basement membrane disease","volume":"7","author":"Jagannathan","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2025040309385629400_bib12","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.ekir.2023.07.031","article-title":"The characteristics of concurrent anti-glomerular basement membrane nephritis and membranous nephropathy","volume":"8","author":"Bu","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025040309385629400_bib13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025040309385629400_bib14","doi-asserted-by":"publisher","first-page":"929155","DOI":"10.3389\/fimmu.2022.929155","article-title":"Relationship between serum complement C3 levels and outcomes among patients with anti-GBM disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"2025040309385629400_bib15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","article-title":"Membranous nephropathy: core curriculum 2021","volume":"77","author":"Alsharhan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2025040309385629400_bib16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.humimm.2009.04.004","article-title":"The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity","volume":"70","author":"Zhao","year":"2009","journal-title":"Hum Immunol"},{"key":"2025040309385629400_bib17","doi-asserted-by":"publisher","first-page":"27147","DOI":"10.1074\/jbc.M504050200","article-title":"Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement","volume":"280","author":"Borza","year":"2005","journal-title":"J Biol Chem"},{"key":"2025040309385629400_bib18","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.1103368","article-title":"Murine membranous nephropathy: immunization with \u03b13(IV) collagen fragment induces subepithelial immune complexes and Fc\u03b3R-independent nephrotic syndrome","volume":"188","author":"Zhang","year":"2012","journal-title":"J Immunol"},{"key":"2025040309385629400_bib19","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"Van De Logt","year":"2019","journal-title":"Kidney Int"},{"key":"2025040309385629400_bib20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.ajkd.2022.07.014","article-title":"Anemia prevalence, type, and associated risks in a cohort of 5.0 million insured patients in the United States by level of kidney function","volume":"81","author":"Farrington","year":"2023","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf014\/62200589\/sfaf014.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/3\/sfaf014\/62200589\/sfaf014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/3\/sfaf014\/62200589\/sfaf014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T09:45:39Z","timestamp":1743673539000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf014\/8045602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf014","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,27]]},"article-number":"sfaf014"}}